Last $14.12 USD
Change Today -1.14 / -7.47%
Volume 18.9K
TRIV On Other Exchanges
Symbol
Exchange
Berlin
OTC US
As of 8:10 PM 08/20/14 All times are local (Market data is delayed by at least 15 minutes).

trivascular technologies inc (TRIV) Snapshot

Open
$14.75
Previous Close
$15.26
Day High
$15.16
Day Low
$14.01
52 Week High
06/3/14 - $17.99
52 Week Low
04/16/14 - $11.15
Market Cap
286.3M
Average Volume 10 Days
13.6K
EPS TTM
--
Shares Outstanding
20.3M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for TRIVASCULAR TECHNOLOGIES INC (TRIV)

Related News

No related news articles were found.

trivascular technologies inc (TRIV) Related Businessweek News

No Related Businessweek News Found

trivascular technologies inc (TRIV) Details

TriVascular Technologies, Inc., a medical device company, develops and commercializes technologies to advance minimally invasive treatment of abdominal aortic aneurysms (AAA). The company offers ovation system, a stent graft platform for the treatment of AAA through minimally invasive endovascular aortic repair. It is also developing a short-cure fill polymer to reduce the time required for the polymer to solidify; next generation iliac limbs; ovation alto system, a next generation aortic body; and other platform applications. The company markets and sells its products through direct sales organizations in the United States, Germany, and the United Kingdom, as well as through distributors in other markets. TriVascular Technologies, Inc. was incorporated in 2007 and is headquartered in Santa Rosa, California.

253 Employees
Last Reported Date: 04/17/14
Founded in 2007

trivascular technologies inc (TRIV) Top Compensated Officers

Chairman, Chief Executive Officer and Preside...
Total Annual Compensation: $450.0K
Co-Founder and Chief Technology Officer
Total Annual Compensation: $264.0K
Chief Financial Officer and Principal Account...
Total Annual Compensation: $275.0K
Compensation as of Fiscal Year 2013.

trivascular technologies inc (TRIV) Key Developments

TriVascular Technologies, Inc. Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2014

TriVascular Technologies, Inc. announced unaudited consolidated earnings results for the second quarter and six months ended June 30, 2014. For the quarter, the company reported revenue was $7.8 million against $4.83 million a year ago. Loss from operations was $12.74 million against $11.17 million a year ago. Loss before income tax expense was $14.49 million against $12.8 million a year ago. Net loss was $14.57 million against $12.83 million a year ago. Basic and diluted loss per share was $0.87 against $22.33 a year ago. Pro forma net loss was $15.27 million against $12.83 million a year ago. Pro forma basic and diluted loss per share was $0.82 against $1.33 a year ago. EBITDA was $11.91 million against $10.96 million a year ago. Adjusted EBITDA was $11.94 million against $10.68 million a year ago. The increase in revenue was primarily attributable to the growth of U.S. business as expanded commercial rollout of the Ovation platform. For the six months, the company reported revenue was $14.83 million against $7.77 million a year ago. Loss from operations was $25.37 million against $20.89 million a year ago. Loss before income tax expense was $28.89 million against $24.07 million a year ago. Net loss was $28.99 million against $24.12 million a year ago. Basic and diluted loss per share was $3.30 against $41.99 a year ago. Pro forma net loss was $29.63 million against $24.11 million a year ago. Pro forma basic and diluted loss per share was $1.91 against $2.50 a year ago. EBITDA was $24.48 million against $20.29 million a year ago. Adjusted EBITDA was $23.98 million against $19.75 million a year ago.

TriVascular Technologies, Inc. to Report Q2, 2014 Results on Aug 06, 2014

TriVascular Technologies, Inc. announced that they will report Q2, 2014 results After-Market on Aug 06, 2014

TriVascular Technologies, Inc., Q2 2014 Earnings Call, Aug 06, 2014

TriVascular Technologies, Inc., Q2 2014 Earnings Call, Aug 06, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TRIV:US $14.12 USD -1.14

TRIV Competitors

Market data is delayed at least 15 minutes.

Company Last Change
View Industry Companies
 

Industry Analysis

TRIV

Industry Average

Valuation TRIV Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 9.7x
Price/Book 4.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales 6.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TRIVASCULAR TECHNOLOGIES INC, please visit www.trivascular.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.